Counterforce Health Team

Counterforce Health Team

Renewing Isturisa (Osilodrostat) Approval with UnitedHealthcare in Pennsylvania: What to Prepare & When

Answer Box: Renewing Isturisa Coverage with UnitedHealthcare in Pennsylvania UnitedHealthcare typically requires annual prior authorization renewal for Isturisa (osilodrostat), with submission needed 30-60 days before expiration. Key requirements include recent 24-hour urine free cortisol (UFC) levels showing response, endocrinologist notes confirming ongoing need, and safety monitoring documentation. If renewal is
6 min read

How Long Does It Take to Get Orladeyo (berotralstat) Approved by Blue Cross Blue Shield in Ohio? Complete Timeline & Appeal Guide

Answer Box: Getting Orladeyo Approved by Blue Cross Blue Shield in Ohio Timeline: 1-14 days for standard prior authorization, 24-72 hours for urgent cases. Blue Cross Blue Shield Ohio (primarily Anthem) requires prior authorization for Orladeyo (berotralstat) with specialist documentation of hereditary angioedema diagnosis, C1-INH testing, and often step therapy
6 min read

Do You Qualify for Naglazyme (Galsulfase) Coverage by Aetna (CVS Health) in Georgia? Decision Tree & Next Steps

Quick Answer: Your Path to Naglazyme Coverage in Georgia You likely qualify for Naglazyme (galsulfase) coverage through Aetna (CVS Health) if you have confirmed MPS VI diagnosis via enzyme assay or genetic testing, plus documented functional limitations. Aetna requires prior authorization with specialist documentation and baseline assessments (6-minute walk test,
6 min read

How to Get Kuvan (Sapropterin) Covered by UnitedHealthcare in Pennsylvania: Complete Forms, Appeals & Timeline Guide

Answer Box: Getting Kuvan Covered by UnitedHealthcare in Pennsylvania UnitedHealthcare requires prior authorization for Kuvan (sapropterin) in Pennsylvania through OptumRx. You'll need PKU diagnosis documentation, phenylalanine levels, and proof of dietary management. Submit via the UnitedHealthcare Provider Portal with complete clinical records. If denied, Pennsylvania's new
6 min read